For both dose levels, peak plasma concentration, area under the concentration-time curve, and cumulative urinary excretion were significantly higher after administration of amorphous rifaximin than rifaximin-α
Polymorph alpha rifaximin 400 mg
Amorphous rifaximin 400 mg
Area under curve 0-t